Invest in

HIV Treatment

6.5%
1.6%
0.5%

The companies in this Motif sell FDA approved prescription drugs used for the treatment of HIV. The Motif is weighted by the companies HIV sales and the likelihood that the drug the company sells will be used in an HIV regimen See more
6.5%
1.6%
0.5%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Motif Index 1 YR Return
HIV Treatment Benchmark
Open a Motif account to view and trade this basket of stocks:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
23.7% Atripla, Reyataz, Sustiva, Evotaz 0.3%
23.7% Bristol-Myers Squibb Company BMY 0.3%
22.0% Parent Companies of Viiv Healthcare 6.8%
11.5% 8xxxxx 8xxx 8xx 88.8%
10.5% 8xxxxxxxxxxxxxx 8xx 8xx 88.8%
17.1% Biotechnology 9.6%
17.1% Gilead Sciences Inc. GILD 9.6%
16.0% Kaletra,Norvir 42.7%
16.0% AbbVie Inc. ABBV 42.7%
9.6% Edurant, Prezista, Intelence 7.1%
9.6% 8xxxxxx 8 8xxxxxx 8xx 88.8%
6.9% Isentress 1.1%
6.9% 8xxxx 8 8xxxxxx 8xxx 8xxxx 8xx 88.8%
4.7% Generic Manufacturers 16.5%
2.9% 8xxxxxxx 8xx 8xx 88.8%
0.9% 8xxxx 8xxx 8xx 88.8%
0.8% 8xxxxxxx 8x 8xx 88.8%

Quotes delayed 15 mins. Currently Jun 20, 2018 10:47:20 PM. Fields are marked with -- when data is unavailable.